Boniva® Demandas Judiciales
Boniva® is manufactured by Roche Pharmaceuticals and is a bisphosphonate that was first approved for sale in 2003 to treat osteoporosis in postmenopausal women. Boniva® is the only drug approved to be taken once a month by millions of women to prevent osteoporosis. However, Boniva® and other bisphosphonates have been associated with a number of serious and painful side effects.
Reported serious side effects include: femur fractures; atypical femoral fracture; atypical thigh fracture; sudden unusual thigh fractures; atypical subtrochanteric femur fractures; diaphyseal femur fractures; osteonecrosis of the jaw (dead jaw syndrome); esophageal cancer; and possibly other cancers.